文献速递肿瘤 PET/CT神经核医学

基线[68Ga]Ga-DOTA-NOC PET/CT在儿童神经母细胞瘤中的预后价值

Prognostic value of baseline [68Ga]Ga‑DOTA‑NOC PET/CT in paediatric neuroblastoma.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2026-01-16

中位随访30个月,20例进展、11例死亡;多因素Cox分析显示原发肿瘤SUVmax、SUVpeak及全身TL-NOC是PFS的独立预测因素,全身TL-NOC、全身GTV及原发肿瘤TL-NOC是OS的独立预测因素。

要点

  • 基线[68Ga]Ga-DOTA-NOC PET/CT的全身TL-NOC是儿童神经母细胞瘤PFS和OS的独立预测因素。
  • 原发肿瘤SUVmax和SUVpeak与PFS独立相关,全身GTV和原发肿瘤TL-NOC与OS独立相关。
  • 全身TL-NOC>1357.05 SUV×cm3的患者PFS和OS显著更差。

核心结论

  • 基线[68Ga]Ga-DOTA-NOC PET/CT衍生参数,尤其是全身TL-NOC,是儿童神经母细胞瘤PFS和OS的独立预测因素,支持用于风险分层。

主要发现

  • 中位随访30个月(范围10-51个月),20例进展、11例死亡。
  • 高危组(n=38)较非高危组(n=27)原发肿瘤和全身SUVmax更高(p=0.006和0.001),原发肿瘤SUVpeak更高(p=0.013),全身TL-NOC更高(p=0.001),全身GTV更大(p=0.016)。
  • 多因素Cox分析中,原发肿瘤SUVmax(HR=1.07,95%CI:1.02-1.12,P=0.005)、原发肿瘤SUVpeak(HR=1.06,95%CI:1.01-1.11,P=0.025)及全身TL-NOC(每100 SUV×cm3;HR=1.03,95%CI:1.01-1.05,P=0.013)与PFS独立相关。
  • 多因素Cox分析中,全身TL-NOC(每100 SUV×cm3;HR=1.07,95%CI:1.03-1.10,P=0.001)、全身GTV(每50 cm3;HR=1.08,95%CI:1.01-1.16,P=0.028)及原发肿瘤TL-NOC(每100 SUV×cm3;HR=1.08,95%CI:1.01-1.15,P=0.026)是OS的独立预测因素。
  • 全身TL-NOC>1357.05 SUV×cm3可识别PFS和OS显著更差的患者。

关键数值与推荐

  • 全身TL-NOC>1357.05 SUV×cm3提示PFS和OS显著更差。
  • 原发肿瘤SUVmax每增加1单位,PFS风险HR=1.07(95%CI:1.02-1.12,P=0.005)。
  • 全身TL-NOC每增加100 SUV×cm3,PFS风险HR=1.03(95%CI:1.01-1.05,P=0.013),OS风险HR=1.07(95%CI:1.03-1.10,P=0.001)。

临床怎么用

  • 对儿童神经母细胞瘤患者,基线[68Ga]Ga-DOTA-NOC PET/CT测量的全身TL-NOC等参数可用于辅助风险分层。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate the prognostic value of baseline [68Ga]Ga-DOTA-NOC PET/CT-derived volumetric and uptake parameters in paediatric neuroblastoma patients. METHODS: Sixty‑five newly diagnosed patients underwent baseline [68Ga]Ga‑DOTA‑NOC PET/CT. Primary‑tumour and whole‑body metrics were measured: SUVmax, SUVmean, SUVpeak (standardized uptake values), Gross Tumour Volume (GTV), and Total Lesion NOC (TL‑NOC). Cox regression evaluated predictors of progression‑free survival (PFS) and overall survival (OS). RESULTS: Over a median 30‑month follow‑up (range 10-51), 20 progressed and 11 died. High‑risk cases (n = 38) had higher uptake and volumes than non high‑risk (n = 27): primary‑tumour and whole‑body SUVmax (p = 0.006 and 0.001); primary‑tumour SUVpeak (p = 0.013); whole‑body TL‑NOC(p = 0.001) and GTV (p = 0.016). On multivariable Cox analysis, primary‑tumour SUVmax (HR = 1.07, 95% CI: 1.02-1.12, P = 0.005) and SUVpeak (HR = 1.06, 95% CI: 1.01-1.11, P = 0.025), as well as whole‑body TL‑NOC (per 100 SUV × cm3; HR = 1.03, 95% CI: 1.01-1.05, P = 0.013), remained independently associated with PFS, whereas whole‑body TL‑NOC (per 100 SUV × cm3; HR = 1.07, 95% CI: 1.03-1.10, P = 0.001), whole‑body GTV (per 50 cm3; HR = 1.08, 95% CI: 1.01-1.16, P = 0.028) and primary‑tumour TL‑NOC (per 100 SUV × cm3; HR = 1.08, 95% CI: 1.01-1.15, P = 0.026) were independent predictors of OS. A whole‑body TL‑NOC > 1357.05 SUV × cm3 identified patients with significantly worse PFS and OS. CONCLUSION: Parameters derived from [68Ga]Ga‑DOTA‑NOC PET/CT, especially whole‑body TL‑NOC, are independent predictors of PFS and OS in neuroblastoma, supporting their use for risk stratification.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Xu Q, Chen Y, Song J, et al. Prognostic value of baseline [68Ga]Ga‑DOTA‑NOC PET/CT in paediatric neuroblastoma. Eur J Nucl Med Mol Imaging. 2026. PMID: 41543548. doi:10.1007/s00259-025-07745-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。